髓样分化因子2介导脓毒症相关性脑病的作用机制
该研究采用胎鼠脑皮质神经元体外模型,用0、1、5、10 g/L LPS刺激24小时,以LDH释放和IL-6、IL-1β水平确定10 g/L为建立SAE神经炎症模型的最佳剂量。10 g/L LPS组神经元凋亡、cleaved-caspase-3表达、p-RIPK3/RIPK3比值及MD2表达均较空白对照组显著升高,提示典型凋亡与坏死性凋亡并存且MD2上调可能起关键作用。MD2干扰肽组IL-6、IL-1β水平及LDH释放较LPS组显著降低,表明干扰MD2可减轻LPS诱导的神经炎症和神经元死亡。
要点
- 10 g/L LPS刺激24小时可诱导神经元显著死亡,LDH相对释放1.45±0.04 vs 空白对照1.00±0.00(P<0.01)。
- 10 g/L LPS组IL-6相对水平1.94±0.04 vs 对照1.00±0.00、IL-1β 1.53±0.09 vs 1.00±0.00,均P<0.01。
- LPS组cleaved-caspase-3/GAPDH 1.55±0.10 vs 对照1.00±0.00(P<0.01),p-RIPK3/RIPK3比值1.54±0.06 vs 1.00±0.00(P<0.05),提示凋亡与坏死性凋亡并存。
- LPS组MD2/GAPDH 1.91±0.07 vs 对照1.00±0.00(P<0.01),MD2表达上调可能参与神经炎症和神经元死亡。
- MD2干扰肽组IL-6相对水平1.16±0.08 vs LPS组1.94±0.04、IL-1β 1.15±0.05 vs 1.75±0.09(均P<0.01),LDH相对释放1.09±0.01 vs 1.44±0.04(P<0.05)。
适用人群与场景
- 体外培养的胎鼠(妊娠14-18天C57BL/6J小鼠)脑皮质神经元,用于建立LPS诱导的脓毒症相关性脑病神经炎症模型。
诊断标准与关键阈值
- 以0、1、5、10 g/L LPS刺激神经元24小时,根据LDH释放及IL-6、IL-1β水平确定10 g/L为建立体外SAE神经炎症模型的最佳剂量。
研究设计与关键结果
- 研究类型为体外细胞实验;取妊娠14-18天C57BL/6J小鼠胎鼠脑皮质组织培养神经元,用0(对照)、1、5、10 g/L LPS刺激24小时。
- 10 g/L LPS刺激24小时神经元LDH相对释放1.45±0.04 vs 空白对照1.00±0.00(P<0.01),IL-6相对水平1.94±0.04 vs 1.00±0.00、IL-1β相对水平1.53±0.09 vs 1.00±0.00(均P<0.01)。
- LPS组较空白对照组细胞凋亡增加,cleaved-caspase-3/GAPDH 1.55±0.10 vs 1.00±0.00(P<0.01),p-RIPK3/RIPK3比值1.54±0.06 vs 1.00±0.00(P<0.05),神经元周围p-RIPK3表达增加。
- LPS组MD2/GAPDH 1.91±0.07 vs 空白对照1.00±0.00(P<0.01),神经元周围MD2表达增加。
- MD2干扰肽组(LPS+TC)较LPS组IL-6相对水平1.16±0.08 vs 1.94±0.04、IL-1β相对水平1.15±0.05 vs 1.75±0.09(均P<0.01),LDH相对释放1.09±0.01 vs 1.44±0.04(P<0.05)。
证据类型、等级与局限
- 证据类型:体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为LPS通过MD2诱导神经元炎症反应,最终导致凋亡和坏死性凋亡;干扰MD2可减轻炎症并抑制神经元死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the role and underlying mechanism of human myeloid differentiation protein 2 (MD2) in the process of neuronal death induced by lipopolysaccharide (LPS) by establishing an in vitro model of sepsis-associated encephalopathy (SAE) by LPS.
METHODS: Healthy C57BL/6J mice at 14-18 days of gestation were selected, and brain cortical tissue was taken from fetal mice. Neurons were stimulated with 0 (control), 1, 5 and 10 g/L of LPS for 24 hours. The release of lactate dehydrogenase (LDH) was detected and the death of neurons was observed. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of inflammatory factors interleukins (IL-6, IL-1β), in order to determine the optimal dose of LPS for establishing an in vitro neuroinflammation model of SAE. The cells were divided into blank control group and LPS group. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) was used to discover apoptosis. Western blotting was used to detect the expression of the relevant protein markers activated caspase-3, necroptosis-associated protein neuronal receptor-interacting serine/threonine-protein kinase 3 (RIPK3) and phosphorylated RIPK3 (p-RIPK3). Immunofluorescence chemical staining was used to detect the expressions of p-RIPK3 and microtubule-associated protein 2 (MAP2) to evaluate the type of cell death and the degree of neuronal death. Western blotting was used to detect MD2 expression. Immunofluorescence chemical staining was performed to observe the expression and distribution of p-RIPK3 and MD2 in neurons to assess whether MD2 was involved in the inflammatory response promoting neuronal death. In addition, the cells were divided into blank control group, LPS group, and MD2 interfering peptide group (LPS+TC group), and the levels of IL-6, IL-1β and LDH were detected to evaluate whether interfering with MD2 can alleviate LPS induced neuroinflammation.
RESULTS: 10 g/L LPS induced notable neuronal death, and the release of LDH in neurons stimulated with this concentration for 24 hours was significantly higher than that in the blank control group (relative release: 1.45±0.04 vs. 1.00±0.00, P < 0.01), indicating apoptosis and necroptosis occurred in neurons, and the levels of inflammatory factors IL-6 and IL-1β were remarkable increased [IL-6 (relative level): 1.94±0.04 vs. 1.00±0.00, IL-1β (relative level): 1.53±0.09 vs. 1.00±0.00, both P < 0.01]. Compared with the blank control group, the apoptosis of cells, cleaved-caspase-3 expression, the p-RIPK3/RIPK3 ratio, and p-RIPK3 expression around neurons in the LPS group were significantly increased [cleaved-caspase-3/GAPDH: 1.55±0.10 vs. 1.00±0.00, P < 0.01; p-RIPK3/RIPK3 ratio (relative value): 1.54±0.06 vs. 1.00±0.00, P < 0.05], which suggested that typical apoptosis and necroptosis apoptosis occurred in neurons in the septic environment. Furthermore, MD2 expression was significantly increased in the LPS group compared with the blank control group (MD2/GAPDH: 1.91±0.07 vs. 1.00±0.00, P < 0.01), and MD2 expression around neurons was increased, indicating that LPS-induced MD2 upregulation may play a key role in neuroinflammation and induction of neuronal death in sepsis. In addition, compared with the LPS group, the MD2-interfering peptide could reduce the expression levels of inflammatory factors IL-6 and IL-1β [IL-6 (relative level): 1.16±0.08 vs. 1.94±0.04, IL-1β (relative level): 1.15±0.05 vs. 1.75±0.09, both P < 0.01] and decrease LDH release (relative release: 1.09±0.01 vs. 1.44±0.04, P < 0.05).
CONCLUSIONS: LPS induced neuronal inflammatory responses via MD2, which ultimately leads to apoptosis and necroptosis. Interfering with MD2 reduces inflammation and inhibits neuronal death.
参考来源
- Jia Q, Gu T, Li Y, et al. [Mechanism of myeloid differentiation factor 2 on mediating sepsis-associated encephalopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37987132. doi:10.3760/cma.j.cn121430-20230506-00346
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。